Abivax News and Activities

Presence

Abivax is a biotechnology company that develops therapies for chronic inflammatory diseases. Its main products and services include drug candidates and clinical development programs for patients, healthcare providers, and research partners.

Abivax products and services overview:

Drug candidates
Clinical development
Inflammation therapies
Gastroenterology treatments
Immunology research

Revenue: ~$10 million

Employees: 60

Headquarters: Paris, France

Abivax is one of the...

Abivax is a company listed under the stock ticker ABVX (FR).

Executives

View the org chart displaying its 33 main executives

Most searched biographies at Abivax

Popular executive movements at Abivax

Laurence Roure who was Associate Director, Clinical Operations, becomes Director, Clinical Operations (posted on March 25 2026).
Michael Nesrallah has joined the company as Chief Commercial Officer (posted on March 25 2026).
Keith Fournier has joined the company as Senior Vice President, Global Regulatory Affairs (posted on March 25 2026).

Click here to view some more movements at Abivax

Create your alert
to follow the executive moves at Abivax.